People · Operator

LEE M. COOPER

Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology

1
Companies
4
Filings
$59.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Triumvira Immunologics Inc.BiotechnologySeries C$59.7M$1.8B2021
Operator network

LEE M. COOPER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

SCOTT C. SMITH · 3 companies · 1 sharedSCOTT C. SMITHBRIAN M. BLOOM · 2 companies · 1 sharedBRIAN M. BLOOMCYNTHIA C. COLLINS, MBA · 1 companies · 1 sharedCYNTHIA C. COLLIN…CYNTHIA M. COLLINS, MBA · 1 companies · 1 sharedCYNTHIA M. COLLIN…DANIEL C. JANSE · 1 companies · 1 sharedDANIEL C. JANSEELIZABETH C. WILLIAMS · 1 companies · 1 sharedELIZABETH C. WILL…JON C. IRVIN · 1 companies · 1 sharedJON C. IRVINJURGEN M. ECKHARDT · 1 companies · 1 sharedJURGEN M. ECKHARDTPAUL LAMMERS, MD, MSc · 1 companies · 1 sharedPAUL LAMMERS, MD,…SCOTT M. SMITH · 1 companies · 1 sharedSCOTT M. SMITHSHAAN C. GANDHI, MD, DPhil · 1 companies · 1 sharedSHAAN C. GANDHI, …TERESA C. MCROBERTS · 1 companies · 1 sharedTERESA C. MCROBER…WIDYA M. MULYASASMITA · 1 companies · 1 sharedWIDYA M. MULYASAS…Triumvira Immunologics Inc. · $59.7M raisedTriumvira Immunologic…LEE M. COOPERLC
LEE M. COOPER Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside LEE M. COOPER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
SCOTT C. SMITH13
BRIAN M. BLOOM12
DANIEL C. JANSE11
JURGEN M. ECKHARDT11
TERESA C. MCROBERTS11
PAUL LAMMERS, MD, MSc11
ELIZABETH C. WILLIAMS11
JON C. IRVIN11
WIDYA M. MULYASASMITA11
SHAAN C. GANDHI, MD, DPhil11
CYNTHIA M. COLLINS, MBA11
CYNTHIA C. COLLINS, MBA11
SCOTT M. SMITH11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.